Literature DB >> 29076048

Prevalence of hepatitis C virus infection according to the year of birth: identification of risk groups.

K Neukam1,2, E Ridruejo3,4, P Pérez5,4, R H Campos5,4, A P Martínez6, F A Di Lello7,8.   

Abstract

Hepatitis C virus (HCV) screening according to the year of birth is recommended is some countries based on epidemiological data. The aim of this study was to analyze anti-HCV prevalence among people born between 1905 and 2015 in Argentina. Patients attending a tertiary care hospital in Buenos Aires, Argentina, from 2001 to 2015, who had a determination of anti-HCV, were included. Of 22,079 patients analyzed, 1,152 (5.2%; 95% confidence interval [CI]: 4.9%-5.5%) patients showed positive anti-HCV and 729 (3.3%; 95% CI: 3.1%-3.5%) patients showed detectable viremia. Three risk groups were identified (HCV prevalence): low-risk group-outpatient clinics/emergencies (2.8%); intermediate-risk group-in-patients (8%); and high-risk group-dialysis/transplants (27.2%). In the low-risk group, being born in 1973 or before was identified as a cut-off value for the risk of anti-HCV acquisition (area under the receiver-operator characteristic curve: 75.1 [95% asymptotic CI: 0.732-0.770; p < 0.001]). Ninety-one patients born after 1973 (0.8%) showed positive anti-HCV versus 457 individuals born in 1973 or before (5.8%), p < 0.001. In this group, positive anti-HCV was observed in 252 females (2.1%) and 296 males (4.1%), p < 0.001. In a multivariate analysis adjusted for gender, alanine-aminotransferase levels and HIV coinfection, being born in 1973 or before was independently identified as a risk for positive anti-HCV (adjusted odds ratio: 14.234 [95% CI: 9.993-20.277]; p < 0.001). People born in 1973 or before without other risk factors should be included in screening programs to link the highest possible number of HCV-infected patients to appropriate care and treatment.

Entities:  

Keywords:  Hepatitis C virus; Patient management; Prevalence; Screening programs; Year of birth

Mesh:

Substances:

Year:  2017        PMID: 29076048     DOI: 10.1007/s10096-017-3123-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  [Epidemiology of HCV infection in Argentina].

Authors:  Oscar Fay; Jorge Rey; Sara Vladimirsky
Journal:  Acta Gastroenterol Latinoam       Date:  2006-06

Review 2.  Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America.

Authors:  Cristina Gómez-Gutiérrez; Norberto C Chávez-Tapia; Guadalupe Ponciano-Rodríguez; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2015 Nov-Dec       Impact factor: 2.400

Review 3.  Epidemiological update of hepatitis B, C and delta in Latin America.

Authors:  Mónica V Alvarado-Mora; João R Rebello Pinho
Journal:  Antivir Ther       Date:  2013-06-21

4.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

5.  Prevalence of HIV and other sexually transmitted infections among female commercial sex workers in Argentina.

Authors:  María A Pando; Carolina Berini; Mariel Bibini; Mauro Fernández; Elena Reinaga; Sergio Maulen; Rubén Marone; Mirna Biglione; Silvia M Montano; Christian T Bautista; Mercedes Weissenbacher; José L Sanchez; María M Avila
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

Review 6.  Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  V Bhargavi Rao; Nur Johari; Philipp du Cros; Janey Messina; Nathan Ford; Graham S Cooke
Journal:  Lancet Infect Dis       Date:  2015-05-05       Impact factor: 25.071

7.  Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina.

Authors:  Noemí del Pino; José Raúl Oubiña; Francisco Rodríguez-Frías; Juan Ignacio Esteban; María Buti; Teresa Otero; Josep Gregori; Damir García-Cehic; Silvia Camos; María Cubero; Rosario Casillas; Jaume Guàrdia; Rafael Esteban; Josep Quer
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

8.  Phylodynamics of hepatitis C virus subtype 2c in the province of Córdoba, Argentina.

Authors:  Viviana E Ré; Andrés C A Culasso; Silvia Mengarelli; Adrián A Farías; Fabián Fay; María B Pisano; Osvaldo Elbarcha; Marta S Contigiani; Rodolfo H Campos
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

9.  Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.

Authors:  Diego M Flichman; Jorgelina L Blejer; Beatriz I Livellara; Viviana E Re; Sonia Bartoli; Juan A Bustos; Claudia P Ansola; Susana Hidalgo; Martin E Cerda; Alicia E Levin; Adriana Huenul; Victoria Riboldi; Elena M C Treviño; Horacio J Salamone; Felix A Nuñez; Robert J Fernández; Juan F Reybaud; Rodolfo H Campos
Journal:  BMC Infect Dis       Date:  2014-04-23       Impact factor: 3.090

Review 10.  Hepatitis C in Argentina: epidemiology and treatment.

Authors:  Luis Alejandro Gaite; Sebastián Marciano; Omar Andrés Galdame; Adrián Carlos Gadano
Journal:  Hepat Med       Date:  2014-05-27
View more
  1 in total

1.  Prevalence of hepatitis C virus infection in patients with end-stage renal disease in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Bertha Huarez; Akram Hernández-Vásquez; Diego Azañedo; Rodrigo Vargas-Fernández; Daniel Comandé; Ysela Agüero-Palacios
Journal:  Arch Virol       Date:  2022-10-05       Impact factor: 2.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.